Analytical Data
-
Gene name
RNF39
- Application
-
Alternative Names
HZF; HZFW; HZFw1; LIRF
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H2S5
-
Expression Region
Met1~Ser420
-
Molecular Weight
49kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RNF39, a member of the RING finger protein family, has garnered significant interest in the field of molecular biology due to its potential role in regulating various cellular processes, including ubiquitination, protein degradation, and signal transduction. As a ubiquitin E3 ligase, RNF39 contributes to the post-translational modification of target proteins, which can impact essential regulatory pathways such as cell cycle progression and apoptosis. Recent studies have linked RNF39 to several diseases, including cancer and neurodegenerative disorders, highlighting its significance in pathophysiological processes. The characterization of RNF39 recombinant protein is crucial for elucidating its functional mechanisms, interactions with substrate proteins, and overall biological significance. By generating and studying RNF39 in a recombinant form, researchers aim to gain insights into its structural properties and enzymatic activity, paving the way for potential therapeutic strategies targeting RNF39-related pathways. Furthermore, understanding the regulatory mechanisms and signaling networks involving RNF39 can illuminate its role in cellular homeostasis and disease development, ultimately leading to the identification of novel biomarkers or drug targets in oncology and other fields.
